Ambu A/S (CPH:AMBU.B)
91.25
+1.10 (1.22%)
At close: Jan 16, 2026
Ambu A/S Market Cap
Ambu A/S has a market cap or net worth of 24.4 billion as of January 16, 2026. Its market cap has decreased by -14.29% in one year.
Market Cap
24.40B
Enterprise Value
24.08B
Revenue
6.04B
Ranking
n/a
PE Ratio
40.20
Stock Price
91.25
Market Cap Chart
Since August 8, 1994, Ambu A/S's market cap has increased from 290.04M to 24.40B, an increase of 8,311.87%. That is a compound annual growth rate of 15.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 24.40B | 4.18% |
| Dec 30, 2025 | 23.42B | -15.47% |
| Dec 30, 2024 | 27.70B | -1.11% |
| Dec 29, 2023 | 28.01B | 23.89% |
| Dec 30, 2022 | 22.61B | -48.49% |
| Dec 30, 2021 | 43.90B | -32.73% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.70T |
| Genmab | 132.19B |
| Coloplast | 129.90B |
| ALK-Abelló | 50.43B |
| Demant | 49.63B |
| H. Lundbeck | 42.61B |
| Zealand Pharma | 28.88B |
| GN Store Nord | 17.21B |